Location: Burlington, VT
CIK: 0001618205 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 8, 2023
Total Value: $133M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 728,585 | $46.59M | 34.9% | $63.95 * | $44.70 | +31.9% | COM | 110122108 |
| PRTA | PROTHENA CORP PLC | 156,111 | $10.66M | 8.0% | $68.28 * | $39.91 | +61.6% | SHS | G72800108 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 84,240 | $7.944M | 6.0% | $94.30 * | $72.40 | +35.0% | COM | 64125C109 |
| — | BIODESIX INC | 5,039,633 | $6.199M | 4.6% | $1.23 | $6.11 | — | COM | 09075X108 |
| ACAD | ACADIA PHARMACEUTICALS INC | 249,400 | $5.973M | 4.5% | $23.95 * | $35.16 | -36.8% | COM | 004225108 |
| — | QUIDELORTHO CORP | 65,203 | $5.403M | 4.0% | $82.86 | $69.01 | — | COM | 74838J101 |
| ELUT | AZIYO BIOLOGICS INC | 1,655,184 | $3.906M | 2.9% | $2.36 * | $5.84 | -64.0% | COM | 05479K106 |
| — | IMMUNOGEN INC | 190,000 | $3.585M | 2.7% | $18.87 | $6.13 | — | COM | 45253H101 |
| UTHR | UNITED THERAPEUTICS CORP | 15,000 | $3.311M | 2.5% | $220.75 | $93.09 | +137.9% | COM | 91307C102 |
| OVV | OVINTIV INC | 84,200 | $3.205M | 2.4% | $38.07 * | $33.44 | +8.1% | COM | 69047Q102 |
| HROW | HARROW HEALTH INC | 150,000 | $2.856M | 2.1% | $19.04 * | $6.05 | +264.0% | COM | 415858109 |
| PHR | PHREESIA INC | 82,700 | $2.565M | 1.9% | $31.01 | $23.06 | +35.7% | COM | 71944F106 |
| MASI | MASIMO CORP | 15,280 | $2.514M | 1.9% | $164.55 * | $81.54 | +113.5% | COM | 574795100 |
| FHTX | FOGHORN THERAPEUTICS INC | 264,843 | $1.864M | 1.4% | $7.04 | $19.16 | -63.5% | COM | 344174107 |
| — | INHIBRX INC | 70,448 | $1.829M | 1.4% | $25.96 | $31.33 | — | COM | 45720L107 |
| — | ACCELERATE DIAGNOSTICS INC | 2,252,388 | $1.824M | 1.4% | $0.81 | $19.28 | — | COM | 00430H102 |
| ALKS | ALKERMES PLC | 50,000 | $1.565M | 1.2% | $31.30 * | $21.00 | +44.2% | SHS | G01767105 |
| ATEC | ALPHATEC HOLDINGS INC | 80,000 | $1.438M | 1.1% | $17.98 * | $9.84 | +58.3% | COM | 02081G201 |
| — | EQUITRANS MIDSTREAM CORPORATIO | 133,050 | $1.272M | 1.0% | $9.56 | $8.31 | — | COM | 294600101 |
| CORT | CORCEPT THERAPEUTICS INC | 50,000 | $1.113M | 0.8% | $22.25 * | $6.85 | +235.8% | COM | 218352102 |
| APLS | APELLIS PHARMACEUTICALS INC | 12,000 | $1.093M | 0.8% | $91.10 * | $37.18 | +132.1% | COM | 03753U106 |
| — | SOLENO THERAPEUTICS INC | 245,127 | $1.052M | 0.8% | $4.29 | $0.69 | — | COM | 834203101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 38,000 | $1.05M | 0.8% | $27.62 * | $38.07 | -34.3% | COM | 74366E102 |
| DCGO | DOCGO INC | 110,000 | $1.031M | 0.8% | $9.37 * | $7.69 | +14.1% | COM | 256086109 |
| — | IVERIC BIO INC | 25,000 | $984K | 0.7% | $39.34 | $16.94 | — | COM | 46583P102 |
| STOK | STOKE THERAPEUTICS INC | 85,000 | $904K | 0.7% | $10.63 | $13.12 | -18.9% | COM | 86150R107 |
| VTYX | VENTYX BIOSCIENCES INC | 26,400 | $866K | 0.6% | $32.80 * | $22.39 | +54.0% | COM | 92332V107 |
| — | BLUEBIRD BIO INC | 249,200 | $820K | 0.6% | $3.29 | $19.29 | — | COM | 09609G100 |
| CYTK | CYTOKINETICS INC | 25,000 | $816K | 0.6% | $32.62 * | $27.06 | +36.7% | COM | 23282W605 |
| — | PIONEER NATURAL RESOURCES CO | 3,800 | $787K | 0.6% | $207.18 | $145.33 | — | COM | 723787107 |
| TXG | 10X GENOMICS INC | 12,000 | $670K | 0.5% | $55.84 * | $36.27 | +49.2% | CL A COM | 88025U109 |
| — | SILK ROAD MEDICAL INC | 20,000 | $650K | 0.5% | $32.49 | $37.42 | — | COM | 82710M100 |
| TVTX | TRAVERE THERAPEUTICS INC | 40,000 | $614K | 0.5% | $15.36 * | $20.49 | -11.2% | COM | 89422G107 |
| — | 2SEVENTY BIO INC | 59,833 | $606K | 0.5% | $10.12 | $19.43 | — | COM | 901384107 |
| — | CHINOOK THERAPEUTICS INC | 15,000 | $576K | 0.4% | $38.42 | $23.13 | — | COM | 16961L106 |
| — | KARYOPHARM THERAPEUTICS INC | 291,332 | $521K | 0.4% | $1.79 | $13.75 | — | COM | 48576U106 |
| — | KINIKSA PHARMACEUTICALS LTD | 30,000 | $422K | 0.3% | $14.08 | $13.10 | — | COM | G5269C101 |
| XENE | XENON PHARMACEUTICALS INC | 10,000 | $385K | 0.3% | $38.50 * | $30.24 | +31.4% | COM | 98420N105 |
| ARVN | ARVINAS INC | 15,000 | $372K | 0.3% | $24.82 * | $16.46 | +56.2% | COM | 04335A105 |
| AXGN | AXOGEN INC | 40,000 | $365K | 0.3% | $9.13 * | $9.32 | 0.0% | COM | 05463X106 |
| HALO | HALOZYME THERAPEUTICS INC | 10,000 | $361K | 0.3% | $36.07 * | $51.20 | -33.4% | COM | 40637H109 |
| KALV | KALVISTA PHARMACEUTICALS INC | 40,000 | $360K | 0.3% | $9.00 * | $18.69 | -50.7% | COM | 483497103 |
| PGNY | PROGYNY INC | 9,000 | $354K | 0.3% | $39.34 * | $33.03 | +9.3% | COM | 74340E103 |
| FOLD | AMICUS THERAPEUTICS INC | 28,000 | $352K | 0.3% | $12.56 * | $14.56 | -18.5% | COM | 03152W109 |
| XNCR | XENCOR INC | 12,300 | $307K | 0.2% | $24.97 * | $15.78 | +72.4% | COM | 98401F105 |
| SRPT | SAREPTA THERAPEUTICS INC | 2,500 | $286K | 0.2% | $114.52 * | $100.79 | +27.8% | COM | 803607100 |
| KROS | KEROS THERAPEUTICS INC | 7,000 | $281K | 0.2% | $40.18 * | $46.71 | -6.2% | COM | 492327101 |
| CGEM | CULLINAN ONCOLOGY INC | 25,114 | $270K | 0.2% | $10.76 | $40.60 | -73.8% | COM | 230031106 |
| IFRX | INFLARX NV | 50,000 | $223K | 0.2% | $4.46 | $3.70 | +20.9% | COM | N44821101 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 20,000 | $141K | 0.1% | $7.04 * | $6.02 | +33.4% | COM | 09058V103 |
| GOSS | GOSSAMER BIO INC | 99,088 | $119K | 0.1% | $1.20 | $10.02 | -87.6% | COM | 38341P102 |
| — | G1 THERAPEUTICS INC | 40,000 | $99,600 | 0.1% | $2.49 | $33.05 | — | COM | 3621LQ109 |
| — | YIELD10 BIOSCIENCE INC | 18,750 | $41,625 | 0.0% | $2.22 | $6.02 | — | COM | 98585K102 |
| — | NEKTAR THERAPEUTICS | 28,000 | $16,106 | 0.0% | $0.58 | $15.38 | — | COM | 640268108 |